AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107. A total of 130 filers reported holding AIMMUNE THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is 3.37 and the average weighting 0.9%.
Quarter-by-quarter ownership
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chicago Capital Management, LLC | 414,500 | $14,280,000 | 13.67% |
| Burrage Capital Management LLC | 332,546 | $11,456,000 | 9.04% |
| Penn Mutual Asset Management, LLC | 158,783 | $5,470,000 | 7.72% |
| First Trust Capital Management L.P. | 525,598 | $18,107,000 | 4.87% |
| GARDNER LEWIS ASSET MANAGEMENT L P | 653,711 | $22,520,000 | 4.08% |
| ALPINE ASSOCIATES MANAGEMENT INC. | 2,075,100 | $71,488,000 | 3.76% |
| S. MUOIO & CO. LLC | 90,000 | $3,101,000 | 3.52% |
| EQUITEC PROPRIETARY MARKETS, LLC | 124,700 | $4,296,000 | 3.27% |
| GABELLI & Co INVESTMENT ADVISERS, INC. | 501,719 | $17,284,000 | 3.11% |
| WATER ISLAND CAPITAL LLC | 1,062,245 | $36,594,000 | 3.11% |